South San Francisco, CA, United States of America

Cathal S Mahon

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2020 - 2021)
  • San Francisco, CA (US) (2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Cathal S Mahon: Innovator in Protein Therapeutics

Introduction

Cathal S Mahon is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of protein therapeutics, particularly in developing fusion proteins that can cross the blood-brain barrier. With a total of 5 patents to his name, Mahon's work is paving the way for innovative treatments for various genetic disorders.

Latest Patents

Mahon's latest patents include groundbreaking work on fusion proteins comprising acid alpha-glucosidase enzymes. These proteins are designed to be transported across the blood-brain barrier and are aimed at treating Pompe disease. Another notable patent involves fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes, which also target the blood-brain barrier and are intended for treating Sanfilippo syndrome A. These advancements highlight Mahon's commitment to addressing complex medical challenges through innovative solutions.

Career Highlights

Cathal S Mahon is currently associated with Denali Therapeutics Inc., a company known for its focus on developing therapies for neurodegenerative diseases. His role at Denali Therapeutics allows him to leverage his expertise in protein engineering to create impactful treatments. Mahon's contributions to the field have been recognized through his patents, which reflect his innovative approach to solving critical health issues.

Collaborations

Mahon has collaborated with notable colleagues, including Mihalis S Kariolis and Adam P Silverman. These partnerships enhance the research and development efforts at Denali Therapeutics, fostering an environment of innovation and collaboration.

Conclusion

Cathal S Mahon is a distinguished inventor whose work in protein therapeutics is making a significant impact in the medical field. His innovative patents and collaborations are essential in the pursuit of effective treatments for genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…